✨ Your Portfolio is fetched and updated from zerodha.

Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (232 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
41.57
4,53,750
66.60
1,51,314
29.19
1,13,225
26.22
1,10,037
19.59
1,04,490
20.69
1,04,266
54.29
1,03,845
25.39
88,979
181
69,869
63.31
67,433
27.73
65,751
37.85
58,745
45.91
41,774
37.25
39,331
37.95
39,315
49.27
34,957
35.70
33,003
122
26,017
106
21,445
-
21,346
29.50
21,312
13.49
21,003
30.98
19,193
31.81
18,927
45.22
15,724
23.97
15,373
21.78
14,696
93.92
12,619
30.55
12,253
56.97
11,794
37.63
11,759
42.06
10,847
61.05
10,824
19.21
10,682
56.52
10,464
27.17
9,791
61.94
9,293
30.77
9,032
32.14
8,202
43.64
7,546
23.75
7,356
-
7,078
27.23
5,900
3.77
5,856
35.46
4,997
25.75
4,344
-
4,212
44.54
3,991
81.43
3,891
32.62
3,757
190
3,587
25.86
3,559
17.84
3,477
33.44
3,397
24.16
3,120
57.61
2,883
8.82
2,600
-
2,599
23.72
2,358
7.07
2,244
32.16
2,166
149
2,124
-
1,883
57.42
1,751
24.73
1,650
28.74
1,599
27.32
1,583
44.08
1,547
16.67
1,464
32.99
1,421
43.06
1,407
18.07
1,379
19.45
1,341
60.14
1,326
21.01
1,262
4.74
1,179
49.19
1,140
25.18
1,068
48.06
1,024
23.15
1,015
23.02
989
-
913
-
910
10.18
894
44.08
884
35.31
823
31.54
811
18.68
767
35.90
737
21.19
639
35.25
637
26.29
540
91.73
535
25.17
506
14.57
506
33.19
494
23.67
469
-
403
29.80
391
19.72
391
38.55
363
43.70
351
33.85
327
35.80
324
64.70
318
67.56
312
15.59
297
-
287
-
272
15.23
268
-
266
24.26
258
43.32
252
30.55
251
22.68
250
25.45
250
-
241
68.33
235
-
219
20.27
211
38.83
208
-
193
22.44
193
15.66
193
37.56
190
13.31
181
26.92
179
37.06
178
26.08
177
13.94
175
17.97
173
660
171
11.99
168
56.46
167
8.25
162
-
159
18.31
157
25.67
156
34.44
155
83.54
152
7.03
152
12.60
147
20.05
135
39.23
134
16.49
134
13.24
128
34.08
126
15.32
123
-
116
-
106
186
105
16.35
100
11.20
98
26.25
98
78.25
95
-
91
18.60
88
104
77
-
76
25.07
70
-
69
9.57
69
6.47
69
-
69
14.30
62
12.93
58
13.26
57
3.12
55
-
55
7.49
54
12.61
53
132
53
15.82
53
-
52
18.46
51
17.36
49
19.89
49
-
48
210
47
59.04
47
-
45
-
45
99.65
44
18.38
43
21.96
42
-
38
24.48
38
-
38
35.51
37
-
35
44.94
34
-
34
14.53
33
6.33
31
7.20
30
112
28
-
27
31.93
27
320
27
6.32
26
11.72
25
7.14
24
25.93
23
10.69
22
-
21
-
21
-
18
27.21
17
37.68
17
51.21
15
99.02
13
-
13
-
13
28.87
13
12.96
13
-
13
-
12
20.65
11
797
10
12.29
9
61.58
9
-
8
-
7
89.76
7
824
7
-
7
62.32
6
-
5
-
5
69.81
4
-
3
-
2
Showing 5 232 of 232 Show More
Market Share

    Select a Metric
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Fermentation Based API Products - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Vaccines - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • Fermentation Capacity (KL)
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Benzimidazole (%)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Results
        Timeline
        Watchlist
        Portfolio
        Alerts
        Stock Screener
        Market
        Raw Material